230 related articles for article (PubMed ID: 22572598)
1. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
Bitterman PB; Polunovsky VA
Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
[TBL] [Abstract][Full Text] [Related]
2. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
Bitterman PB; Polunovsky VA
Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
[TBL] [Abstract][Full Text] [Related]
3. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
5. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
6. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
7. Targeting translation dependence in cancer.
Malina A; Cencic R; Pelletier J
Oncotarget; 2011; 2(1-2):76-88. PubMed ID: 21378410
[TBL] [Abstract][Full Text] [Related]
8. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.
Fagan DH; Fettig LM; Avdulov S; Beckwith H; Peterson MS; Ho YY; Wang F; Polunovsky VA; Yee D
Horm Cancer; 2017 Aug; 8(4):219-229. PubMed ID: 28577281
[TBL] [Abstract][Full Text] [Related]
9. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
[TBL] [Abstract][Full Text] [Related]
10. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppression by small molecule inhibitors of translation initiation.
Chen L; Aktas BH; Wang Y; He X; Sahoo R; Zhang N; Denoyelle S; Kabha E; Yang H; Freedman RY; Supko JG; Chorev M; Wagner G; Halperin JA
Oncotarget; 2012 Aug; 3(8):869-81. PubMed ID: 22935625
[TBL] [Abstract][Full Text] [Related]
12. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy.
Lin CJ; Malina A; Pelletier J
Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439
[TBL] [Abstract][Full Text] [Related]
13. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F.
Cencic R; Hall DR; Robert F; Du Y; Min J; Li L; Qui M; Lewis I; Kurtkaya S; Dingledine R; Fu H; Kozakov D; Vajda S; Pelletier J
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1046-51. PubMed ID: 21191102
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells.
Walsh D; Arias C; Perez C; Halladin D; Escandon M; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Mohr I
Mol Cell Biol; 2008 Apr; 28(8):2648-58. PubMed ID: 18250159
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutics targeting mRNA translation.
Malina A; Mills JR; Pelletier J
Cold Spring Harb Perspect Biol; 2012 Apr; 4(4):a012377. PubMed ID: 22474009
[TBL] [Abstract][Full Text] [Related]
16. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
[TBL] [Abstract][Full Text] [Related]
17. Translating from cancer to the brain: regulation of protein synthesis by eIF4F.
Kats IR; Klann E
Learn Mem; 2019 Sep; 26(9):332-342. PubMed ID: 31416906
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex.
Cowan JL; Morley SJ
Eur J Biochem; 2004 Sep; 271(17):3596-611. PubMed ID: 15317596
[TBL] [Abstract][Full Text] [Related]
19. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation.
Prabhu S; Saadat D; Zhang M; Halbur L; Fruehauf JP; Ong ST
Oncogene; 2007 Feb; 26(8):1188-200. PubMed ID: 16936779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
